Press Releases

Symeres and Ambagon Therapeutics collaborate on molecular glue research in colorectal cancer

Lonza Launches Media Development Lab in Singapore for Cell Culture Media Optimization

Lonza has announced the launch of its Media Development Lab at its Singapore site.

Multi-Arm PEG Architectures Expand Options for Long-Acting Biologic Development

Biopharma PEG highlights high-purity multi-arm PEG reagents designed to support PEGylation research and therapeutic conjugation development

eClinical Solutions elluminate® Platform Supports argenx to Enhance Data Oversight and Efficiency

Innovation allows for real-time data and operational insights to advance immunology breakthroughs

Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back

Kindeva® commemorates 70 years of the pMDI as inventors are inducted into the ‘National Inventors Hall of Fame’

Primerdesign Partners with Origin Sciences to Create Novel Rectal Mucosal Extraction Workflow

Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases

Abselion Appoints Dale Gordon as Chair

Bioprocessing leader to drive continued commercial development and international expansion

Epigenica AB Expands Presence in Japan Through Distribution Agreement with PrimeTech

Epigenica AB today announced a distribution agreement with PrimeTech Co., Ltd., bringing Epigenica’s EpiFinder™ technologies to researchers and laboratories across the Japanese market.

CellCarta Secures Global Exclusivity for Biofidelity's Aspyre® Lung to Advance Targeted Lung Cancer Testing

CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settings.

ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests

The team at ClearNote Health strengthened its leadership team with four key additions.

START Partners with Trialing to Expand Access to Oncology Clinical Trials Across Europe

This partnership will enhance physician awareness of START’s portfolio of trials, streamline referrals, and support patient access to early-phase oncology research.

ELRIG Announces Prof Hazel Screen and Dr Dave Powell as Keynote Speakers for Advances in Cell-based Screening 2026

• Free-to-attend conference takes place at AstraZeneca in Gothenburg, Sweden from 6–7 May • Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery

LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility

LabConnect has officially opened a new central laboratory facility in Wuxi, China, developed in collaboration with Teddy Laboratory (Frontage Laboratories). The site integrates into LabConnect’s global infrastructure to provide unified data, custom kit building, and biorepository services for multi-regional clinical trials. This expansion brings the company to eight global locations, supporting both multinational firms entering China and Asia-Pacific organizations expanding their research internationally.

University of Colorado Grants License to Cirena for RNA-Synthesis Technology

Cirena has secured a license to the University of Colorado Boulder’s patented RNA synthesis technology.

Neuland to open commercial peptide facility as part of planned phased expansion

Abselion Establishes US Subsidiary in Cambridge, MA

Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform

Verista Delivers Comprehensive CSV Services to Ensure Regulatory Compliance and Data Integrity Across the Life Sciences Industry

Services provide expert-led validation, ensuring compliance, efficiency, and data integrity across systems.

Upperton Submits MHRA Licence Application for Annex 1 Sterile Manufacturing Facility Following APS Validation

Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the approval of its new 7,000 sq. ft sterile manufacturing facility. The submission follows the successful execution of multiple aseptic process simulations (APS media-fill batches), completed in accordance with the revised EU GMP Annex 1 (2023) requirements.

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money.